Connect with us

Cannabis News

Allegations of price dumping cast shadow on Portugal’s medical cannabis

Published

on

Portugal has spent the last few years cultivating a reputation as Europe’s gateway to medical cannabis. Exports are booming, the government and local media portray a very vibrant sector with fertile land, progressive laws and a soft regulatory environment.

But behind the glowing export figures, there is growing concern that the country’s success story is due to what some describe as “greenwashing” of the industry.

According to a person familiar with the matter, most of the cannabis that Portugal “exports” is not grown in Portugal. Instead, large companies import low-quality flowers from abroad, process them locally, and then ship them with a Portuguese flag on the label. “Portugal has exported about 35 tons of medicinal cannabis flowers so far,” says the source. “Only about 2 tons were processed here. The rest came from elsewhere.”

The concern is not the import and processing model itself, but the lack of transparency and its impact on the local growers who actually cultivate the plants in Portugal. “They grow cheap overseas for recreational markets,” the person says. “It is then processed in Portugal and sold in pharmacies across Europe at prices that are impossible for real growers. This is clear price dumping.”

Portugal grew on the cheap
According to the source, some European pharmacies are offering Portugal-labeled medical flower for as little as 1.60 euros per gram. Insiders say even the lowest-cost foreign producers can’t get that price and still meet European pharmaceutical standards. “The cheapest production cost I have seen abroad was around 1.40 euros per gram,” explained the source. “Processing in Portugal alone can cost about sixty cents. So how do they sell it for 1.60 euros?” According to them, the reason is simple. On the one hand, these big companies have to show their shareholders that they are moving money and product. On the other hand, they use the availability of capital to drive down the price, gain more market share, and crowd out smaller companies, which are ultimately bought by the same big companies. At the same time, the issue is not only related to the economy. Local producers say quality is also at stake.

Some sources say that many pharmacies turn away from the product with the Portuguese flag, knowing that it is not the real product produced in Portugal. “They think that Portugal is the equivalent of low-quality flower. This hurts the companies that really work here with strict European pharmaceutical practices,” says the person familiar with the matter.

Small farmers struggling to survive
Portugal has a large number of licensed cannabis operators, but few are growing at scale. According to the source, of all the cultivation licenses issued, only a few are actually operational. “Some growers produce one to three kilos per harvest,” says the person. “They have no strategy, no supply chain. It’s just a facade to show that they are somewhat operational, while in fact most of the products are imported and processed locally. These people entered the space without knowing how to run a medical cultivation project.” According to the insider, companies rushing to import, rebrand and dump products on the market are not building a sustainable sector in Portugal.

© Roman Zaiets | Dreamstime

“I expect six to eight companies to fail next year,” they say. “Everybody smiles at conferences, everybody talks about innovation. Nobody talks about cooperation.”

Pressure on regulators and call for research
The person says that regulators are to blame for the situation, but insists that the responsibility lies with companies that lack due diligence and compliance. “Regulators apply the rules. They are not there to do due diligence on behalf of companies,” they say. “Some companies had problems because they had false import documents from foreign suppliers. They blame the regulators for that, and the responsibility should lie with the operators in question, not having the right people doing the right compliance work.”

The source said there are plans to file a complaint with the European Commission under Regulation 2017/1036, which covers dumping of imports from the European Union when it causes injury to a domestic industry. “We are gathering evidence,” they say. “We want regulators to suspend import licenses where dumping is taking place.”

Meanwhile, international monitoring systems are being tightened. According to the source, the EU and the United Nations are implementing new digital tracking and tracing requirements. “Everything will have to be registered. All legal documents, all import and export certificates,” says the insider. “This should be ready in six months.”

Crossroads
Portugal’s promise as the gateway to European cannabis is not dead, but the road ahead is becoming increasingly complex. The sector needs scale, collaboration and transparency if it hopes to avoid the boom and bust cycle seen in North America. “I have nothing against importing and processing,” says the source. “What I find unacceptable is selling a flower with the Portuguese flag when they don’t grow here.”

Cannabis News

Building Nevada’s most vertically integrated cannabis operation

Published

on

By

Nevada is one of the most competitive retail cannabis markets in the United States, and Deep Roots Harvest has been betting for years that the way to win is to control everything. 11 cultivation, processing, manufacturing, extraction and retail locations all under one roof, or pretty close to it. Chris O’Ferrell, Deep Roots Harvest’s Chief Cultivator, runs the growing side of that operation in two facilities totaling 30,000 square feet, pushing 500 pounds of harvested cannabis per week and 2,000 pounds of biomass per month.

“The Source and Deep Roots harvest retail team sells 75 kilos of cannabis daily, 500 kilos weekly, over a third of which is in-house to support the High Heads, Neon Moon and CAMP brands. We cultivate, extract, process, manufacture and work the retail locations,” says Chris. “We have one of the largest market shares in Nevada in terms of retail volume and gross sales.”

That volume is produced by 60 full-time employees at the two sites, and the crop program behind it is, by any reasonable measure, built for efficiency and quality. “Many of the genetics in our library consistently exceed 100 grams per square foot, which directly helps reduce our overall cost per gram,” explains Chris. “We operate with a consumer-first approach, focusing on cost consciousness while providing tasty and competitive offerings. We operate below 70 cents per gram, a benchmark that reflects careful cost management. Getting there and staying there has required compressing costs at all input levels while continuing to invest in technology that moves the needle on quality, cost efficiency and performance.”

© Deep Roots Harvest Chris O’Ferrell, Chief Cultivator at Deep Roots Harvest

Genetics as intended by the producer
The transition of light is a clear example of this, as is the case with cannabis. In the beginning, the company used your classic HPS lights. As LED technology advanced, Deep Roots made the switch. However, it wasn’t just about improving energy efficiency. Chris and the team understood that the more precisely the crop was targeted, the better the final product would be. Energy savings don’t necessarily show up on retail shelves, but crop control does, in the form of flowers that express their genetics the way the grower intended.

To achieve this level of control, the spectrum became a critical tool. “We start with the spring setting, using the blue light to regulate the spacing of the interiors and control the spacing,” he explains. “As the plants progress, we move to the summer spectrum until the end of week eight, switching to a broader spectrum light with balanced wavelengths. This increases the red light, along with other parts of the spectrum to more closely replicate sunlight. We also increase the light intensity during the flowering phase to improve the plant’s photosynthetic performance, accumulation and photosynthetic activity. The parameters support the initiation of flowering, accelerate maturation and allow the plant to reach its potential they allow him to fully express his genetics.”

Nothing is left to chance
At canopy level, plants from the two largest facilities are housed in two-gallon coco pots, chosen to accommodate longer growing periods and larger plant structures. The second facility operates stone wool. Both use substrate sensors in connection with fertigation control, and track performance at different growth stages. Dissolved oxygen is injected into the root zone to increase availability, and a chlorine injection system keeps the lines clear of pathogens with a relatively inexpensive cleanup compared to conventional cleaning programs. “A chlorine injection system is relatively inexpensive to implement, replacing approximately $40,000 in other cleaning and disinfection products annually,” says Chris. “It’s all about being ahead of the curve.”

Pest management is entirely biological, implemented in conjunction with mechanical and cultural controls. “We haven’t had any pest problems,” says Chris. “This was also a decision based on reducing inputs while maintaining, if not improving, the quality of the product.”

Genetics is the backbone of cannabis operations and the gas that drives the company’s engine. They receive the same systematic treatment as all other parts of the operation. A steering committee reviews the portfolio quarterly, withdrawing underperforming cultivars and acquiring replacements based on market data from multiple markets, cross-referenced with gaps in the current menu. The criteria are repeatable agronomic performance, yield, potency, distinctive flavor profile and the ability to wash well for extraction, ensuring strong yields for both rosin and resin production. “All genetics need to adapt to the program,” says Chris. “Unique production, potency and flavor expression that fills the void of what we don’t have on the menu. It’s about finding a commercial cultivar that works well and fits the existing infrastructure. All the cultivars we grow now have a similar and predictable growth structure. The difference is the color, the smell, the experience. They are very close agronomically.”

For more information:
Harvest deep roots
deeprootsharvest.com

Continue Reading

Cannabis News

Marijuana Reform Group Polls Consumers About Freedoms Where They Live Ahead Of 4/20

Published

on

By

Ahead of the unofficial cannabis holiday on 4/20, a leading marijuana reform group is asking consumers to take a poll about the freedoms they experience (or lack thereof) where they live.

The new 2026 Cannabis Freedom Survey from the National Organization for Reform of Marijuana Laws (NORML) includes the questions: “Where you live, how free are adults to legally possess and access cannabis?” and “Where you live, how concerned are you about the legal consequences for cannabis users?”

The survey “is designed to capture the real-time sentiment of cannabis consumers in the United States and abroad to see how individuals experience the politics of cannabis in their daily lives,” NORML said.

The the questioning It also includes a question asking people to choose “the most important step that would increase the freedom of cannabis where you live.”

Options include ending marijuana arrests, legalizing adult marijuana, allowing adults to grow their own cannabis, allowing the sale of legal cannabis, making legal cannabis cheaper, clearing records and resolving past convictions, changing federal cannabis laws and protecting consumer rights (parental, workplace, housing, health).

In addition, it asks whether respondents at the national level fully respect marijuana policy for consumer freedom, whether it is moving in the right direction, stagnant without significant progress, or regressing.

“In some jurisdictions, cannabis comes with real freedom. In others, it still comes with real consequences,” NORML Director of Development JM Pedini said in a press release. “This survey is about capturing that gap, not just what the laws say, but how people actually experience them.”

Pedini told Marijuana Moment that the organization will likely compile the results and release them a few days before 4/20.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Governor vetoes medical cannabis bill

Published

on

By











The veto pen is one of the most powerful tools in the Mississippi Legislature, and Governor Tate Reeves has used it throughout his tenure. This year, his vetoes have mostly targeted public health bills so far, with more to come.

There are three ways Reeves could handle the bills that passed both chambers. He can sign bills he supports and allow them to become law without his signature. He can also block legislation he disagrees with by vetoing a bill or part of it and deferring it to a future legislative session.

As of Wednesday, April 8, he has vetoed four bills, half as many as in the previous two sessions, but Reeves will continue to review the legislation and reject more proposals in the coming days.

Reeves vetoed two medical marijuana bills that passed the Legislature this session, dealing a fatal blow to bills that have already faced friendly chambers. One of the bills, the “Right to Try Medical Cannabis,” contained only one specific provision that Reeves disputed. The original intent of the bill, which Reeves praised, was to expand the opportunity to try medical marijuana to those with debilitating conditions that fall outside the scope of current law.

Read more at Clarion Ledger










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media